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Gender Differences in Cardiovascular Risks of 




The Bronx is the poorest urban county in the country 
-50% of Bronx households include young children living 
below the poverty level. 95% are Black and Latino, including
African-Americans, Caribbean-Americans, and new 
immigrants from Africa. Residents there suffer from high 
rates of diabetes, obesity, and depression (1).
According to the most recent United States (US) 
epidemiologic data (2), the prevalence of obesity among
adolescents is 15.5%. The Bronx has a much higher 
prevalence rate, which reaches 25%. Excessive body 
weight predisposes children to many cardiovascular disease
(CVD) risks; and can lead to hypertension, dyslipidemia, 
impaired glucose metabolism, and insulin resistance in 
their adulthood. However, not all obese children share 
similar risks for developing these conditions. Factors such as
race, gender, economic condition, life style as well as the 
duration of obesity and its degree may also play an 
important role for developing CVD. Although the prevalence
of obesity has been increasing in both boys and girls, few
studies have examined the role of gender in determining
obesity-related CVD risks. 
The aim of our study was to examine the gender-specific
differences in CVD risk factors in obese adolescents in a
high-risk area of an inner city, the Bronx.
ABSTRACT
Objective: The associations between the degree of obesity and 
cardiovascular disease (CVD) risks and the impact of gender differences
with regard to these risk factors are not well understood. The aim of our
study was to examine the gender-specific differences in CVD risk factors
in inner-city minority youths. 
Methods: A total of 269 adolescents (109 males and 160 females) 
were included in this retrospective study. Data on multiple metabolic 
variables were collected. Evaluation of abnormalities in these 
parameters was based on standard criteria. Pearson correlations were
calculated to examine the relationship between body mass index (BMI)
z-score and obesity-related parameters. Chi-square and Fisher’s tests
were used to compare the frequencies of single or multiple cardiovascular
risks in the two gender groups.
Results: In the male group, BMI z-scores showed significant positive
correlations with insulin resistance and diastolic blood pressure. In the
female group, BMI z-scores showed significant positive correlations
with insulin resistance and systolic blood pressure. In both genders, the
prevalence of CVD risks was high, but a similar risk pattern was 
established in both sexes, with dyslipidemia being the highest, 
hypertension the second, and impaired glucose tolerance (IGT) being the
least outstanding. The most important finding in this study was that the
male group had a significantly higher prevalence of systolic hypertension.
Conclusion: Male inner-city minority adolescents show a high 
prevalence of CVD risks associated with obesity. Appropriate risk 
stratification is critical to developing and implementing both therapeutic
and preventive interventions. 
K Ke ey y    w wo or rd ds s: : Obesity, cardiovascular disease, gender, pediatrics, 
adolescents
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This is a cross-sectional retrospective study approved
by our Institutional Review Board. Inclusion criteria were 
obesity, age between 13 and 19 years, and a Tanner stage
development of at least stage III. Exclusion criteria included
underlying diseases that could cause hypertension, type 2
diabetes mellitus or conditions that were being treated with
medications. 
Our data were collected from records of pediatric 
endocrine outpatient clinic visits. The standard techniques
were routinely used in the clinic. Height was measured by
a stadiometer (Holtain Ltd., Crymych, and Wales) and 
weight by a standing scale (Scale-Tronix, Wheaton, Ill.). 
Arterial blood pressure was measured with a cuff of 
appropriate size in sitting position. Body mass index (BMI)
was calculated using the following equation: BMI=weight
(kg)/height2 (m2). This value then was converted to a 
percentile and z-score for each individual patient using 
standard age and sex specific charts (Department of Health
and Human Services 2007). Children with a BMI percentile
value of ≥95% were considered obese.
All subjects underwent a thorough clinical screening,
which included history taking and physical examination. 
A comprehensive laboratory assessment, which included
measurement of thyroid hormone, electrolytes, liver, and
renal function tests, was also performed. In most subjects
this assessment also included a lipid profile in the fasting
state and a 2-hour oral glucose tolerance test (OGTT). All 
biochemical tests were performed in the Montefiore Medi-
cal Center clinical laboratory.
After screening, a total of 269 adolescents (160 females
and 109 males), referred to endocrine clinics for evaluation
of obesity, were included in this study. Among these 
children, 109 (41%) were African-American, 143 (53%) 
were Hispanic, and 17(6 %) were of mixed genetic background.
Data on these patients, expressed as means±standard 
deviations, are presented in Table 1.
The parameters were assumed to be abnormal if the 
following criteria were met: Dyslipidemia was defined as
having a cholesterol (Chol) level of >=200 mg/dL, an HDL of
<=35 mg/dL, an LDL of >=130 mg/dL, or a triglyceride 
level of >=150 mg/dL (3). Abnormal glucose level was 
defined as a fasting plasma glucose level of 100-125 mg/dL
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Table 1. Patient data
Male Female
AA=41 Hispanic=57 Mixed=11 AA=68 Hispanic=86 Mixed=6
Variable Unit N Mean±SD Range R/BMI-Z* P-value N Mean±SD Range R/BMIZ* p-value
Age Year 109 15.6±1.7 13.0-19.0 N/A N/A 160 15.6±1.6 13.0-19.0 N/A N/A
Height cm 109 171.2±9.4 147.4-202.2 N/A N/A 160 161.3±7.2 38.5-177.9 N/A N/A
Weight kg 109 108.8±24.4 64.8-172.9 N/A N/A 160 96.3±22.1 45.3-171.4 N/A N/A
BMI** 109 37.05±7.6 23.4-69.2 1.00 N/A 160 36.8±7.1 23.6-59.0 N/A N/A
BMI Z-score 109 2.43±0.4 1.05-3.3 N/A N/A 160 2.4±0.4 1.1-3.1 1.00 N/A
Insulin-0-min uIU/ml 74 25.9±14.7 4.7-73.3 N/A N/A 106 26.2±14.0 2.9-78.2 N/A N/A
Insulin-2-hour uIU/ml 51 118.1±88.7 16.5-421.0 N/A N/A 63 144.1±113.3 24.8-644.0 N/A N/A
Glucose-0 min mg/dl 92 88.3±11.3 68.0-127.0 0.11 0.290 135 86.4±15.0 56.0-193.0 0.16 0.065
Glucose-2 hour mg/dl 54 111.0±23.9 72.0-193.0 0.03 0.800 64 112.6±25.2 44.0-180.0 0.14 0.264
Quicki*** 72 0.3±0.03 0.26±0.4 -0.29 0.014 104 0.3±0.03 0.3-0.4 -0.30 0.002
BP-systolic mmHg 109 125.6±13.8 96.0-164.0 0.18 0.050 160 119.3±13.0 78.0-164.0 0.23 0.004
BP-diastolic mmHg 109 69.1±9.3 49.0-98.0 0.27 0.005 160 67.1±10.1 36.0-104.0 0.01 0.944
Cholesterol mg/dL 101 167.0±38.1 94.0-264.0 0.01 0.930 145 164.2±29.6 82.0-253.0 0.03 0.756
HDL mg/dL 102 42.2±13.4 23.0-141.0 0.09 0.377 145 45.2±11.3 26.0-94.0 -0.16 0.062
LDL mg/dL 101 100.9±31.9 36.0-191.0 0.00 0.970 145 97.7±26.4 17.0-197.0 0.14 0.099
TG mg/dL 100 125.6±83.0 46.0-569.0 -0.17 0.089 145 105.3±52.0 29.0-302.0 -0.06 0.494
*R/BMI-Z: Correlation Coefficients with BMI Z-score
**BMI: weigh (kg) / height2 (m2)
***QUICKI: 1/[log (Io*Go)]
BMI: body mass index, BP: blood pressure, TG: triglyceride, AA: African-American, N/A: Not availableand a two-hour plasma glucose level of 140-200 mg/dL
(patients with overt type 2 diabetes were excluded from
this study) (4). Insulin resistance (IR) was defined by the
Quantitative Insulin Sensitivity Check Index (QUICKI),
which is calculated as QUICKI=1/ [log (I0*G0)], and values of
less than 0.34 indicate presence of IR (5). Hypertension
was defined as either systolic or diastolic blood pressure
(BP) being equal to or greater than the 95th percentile 
adjusted by age, gender, and height (6).
Data Analysis 
The data were analyzed using a SAS statistical package
(SAS Institute, Cary, NC). Pearson correlations were 
calculated to examine the relationships between BMI z-score
and measurements including BP, glucose levels, QUICKI
and lipids. Chi-square and Fisher’s tests were used to 
compare the frequency of single or multiple cardiovascular
risks in both genders. For all tests, statistical significance
was defined by p values less than 0.05.
Results
In the male group, BMI z-score showed a significant 
negative correlation with QUICKI (r=-0.28 and p=0.014).
Both diastolic and systolic blood pressures were positively
correlated to BMI z-score, the correlations being significant
for diastolic blood pressure (BP-dias) (r=0.265 and p=0.005)
and fairly significant for systolic blood pressure (BP-sys)
(r=0.18 and p=0.05). 
In the female group, BMI z-score showed a significant
negative correlation with QUICKI (r=-0.29 and p=0.002) and
a positive correlation with BP-sys (r=0.225 and p=0.004).
BMI z-score was also positively correlated with BP-dias, but
did not reach statistical significance. 
In both groups, BMI z-score correlated positively with
both fasting plasma glucose and two-hour plasma glucose
levels during OGTT, but neither correlation reached a 
significant level. BMI z-score had no meaningful associations
with any parameters of lipid profile. Patient data are presented
in Table 1.
In both gender groups, the prevalence of CVD risks is
high. There is a similar pattern for each gender, with 
dyslipidemia standing out as the highest risk factor (48.6%
for males and 45.0% for females). Hypertension ranks 
second (32.1% and 20.6% for males and females, 
respectively, p= 0.03), and impaired glucose tolerance (IGT)
ranks as the lowest (9.2% for males and 8.8% for females).
The co-morbidity of combined hypertension and dyslipidemia
is 11.1% for males and 6.9% for females. The co-morbidity
of combined hypertension and IGT is 1.8% for males and
1.9% for females. The co-morbidity of combined IGT and
dyslipidemia is 4.6% for males and 3.1% for females. The
co-morbidity of hypertension, dyslipidemia, plus IGT is 
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Table 2. Comparison of CVD risk prevalence between genders
Female Male p-value
Dysplipidemia 45.0% 48.6% NS
Hypertension 20.6% 32.1% 0.03
IGT 8.8% 9.2% NS
Dysplepidemia+Hypertension 6.9% 11.1% NS
IGT+Dyslipidemia 3.1% 4.6% NS
IGT+Hypertension 1.9% 1.8% NS
IGT+Dyslipidemia+Hypertension 0.6% 0.% NS
↑Glu(0) 5.6% 6.4% NS
↑Glu(2h) 4.4% 4.6% NS
↑BP-systolic 18.8% 29.6% 0.03
↑BP-diastolic 4.4% 5.5% NS
↑Cholesterol 8.8% 15.6% NS
↓HDL 27.5% 31.2% NS
↑LDL 8.8% 12.8% NS
↑TG 13.8% 21.1% NS
Dyslipidemia, bnormality in any of the four parameters in lipid profile;hypertension, either ↑BP-systolic or ↑BP-diastolic
IGT= either ↑Glu(0) or ↑Glu(2h))
IGT: impaired glucose tolerance, BP: blood pressure, NS: non significantapproximately 0.9% for males and 0.6% for females. 
Overall, only 38.8% females and 29.4% males had no 
abnormalities. The male group had a significantly higher
prevalence of systolic hypertension (29.6% vs. 18.8%,
p=0.0057). Detailed data are shown in Table 2 and Figures
1 and 2.
Discussion
In this study, we examined CVD risks of obese 
adolescents residing in one of the poorest inner cities of the
US. The subjects consisted mainly of African-Americans
and Caribbean-Hispanics. Using BMI z-score, we studied
the varying degrees of obesity associated with various risk
factors for CVD. Our results showed an important 
relationship between BMI z-score and IR, namely, the 
higher the BMI z-score, the worse IR. Previous studies in
adults demonstrated IR as the main cause for developing
CVD (7-8). BMI z-scores have a significant impact on BP-sys
in females and a greater impact on BP-dias in males.
Although gender differences in childhood obesity have not
been fully comprehended, previous studies indicate that
the causes and consequences of obesity might differ 
between genders (9). 
The prevalence of dyslipidemia and hypertension 
observed in this present study are much higher than those
reported by previous studies (4-6). One interesting finding is
that dyslipidemia does not seem to be linked with the 
degree of obesity. However, further studies on the etiology
of dyslipidemia are needed to explain this finding. Also, the
impaired OGTT rate in this study is lower than the rates 
reported in several previous studies (10-11). Given that this
is a retrospective study and not all subjects took the OGTT,
this finding may have resulted from the smallness of the
sample size for this test. Most interestingly, we found that
males carry higher risks of systolic hypertension. 
Conclusion
Male subjects among inner-city minority youths carry 
higher CVD risks associated with obesity, specifically with
regard to systolic hypertension. An awareness of this gender 
difference is critical in developing and implementing both 
therapeutic and preventive interventions in this population.
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Figure 1. Frequency of combined CVD risks
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